홈 > 시장보고서 > 의약품 > 신약개발

시장보고서

상품코드

1419079

세계 이중 특이성 항체 치료제 위탁생산 시장 : 적응증별, 투여경로별, 최종사용자별, 국가별, 지역별 산업 분석 - 시장 규모, 시장 점유율 예측(2023년-2030년)

Bispecific Antibody Therapeutics Contract Manufacturing Market, By Indication, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: 2024년 01월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

이중 특이성 항체 치료제 위탁생산 시장 규모는 2022년에 52억 8,910만 달러로 평가되었고, 2023년부터 2030년에 걸쳐 복합 연간 성장률(CAGR) 36.23%로 확대될 전망입니다.

이중 특이성 항체 치료제 위탁생산 시장 - 시장 역학

신규 치료제 개발과 연구개발 투자의 중점화가 시장 수요를 촉진

예측 기간 동안 이중특이적 항체(bsAB) 치료제의 수탁 제조 시장은 주로 신규 치료제의 발견을 목적으로 하는 R&D 노력 증가로 확대될 것으로 예상됩니다. 이 시장은 지난 몇 년간 급격히 확대되고 있으며, 이러한 동향은 분석 기간 동안 계속될 것으로 예상됩니다. 그 주된 이유는 이중특이적 항체의 강력한 파이프라인이며, 아마도 예측 기간을 통해 도입될 것입니다. 게다가 시장의 이익 확대의 주요 요인은 항암제 치료의 파이프라인이 확대되고 있다는 것입니다. 예를 들어 미국 FDA에 따르면 2022년 현재 임상시험 중 이특이성 항체의 85% 이상이 암 치료를 목적으로 하고 있습니다.

또한 이중 특이성 항체요법은 암이나 기타 질환의 치료에 있어서 큰 치료효과를 기대할 수 있기 때문에 유행 이후 수요가 증가하고 있습니다. 또한, 현재 몇몇 이특이적 항체가 임상 개발의 초기 단계에 있습니다. 따라서 향후 몇 년동안 이 점이 시장 성장에 긍정적으로 작용할 것으로 예상됩니다. 또한 이중특이적 항체 치료제 파이프라인이 개발 중이며 시장 확대 기회를 뒷받침할 것으로 예상됩니다.

이중 특이성 항체 치료제 위탁생산 시장 - 세분화 분석 :

세계 이중 특이성 항체 치료제 위탁생산 시장은 적응증, 투여 경로, 최종 사용자, 지역에 따라 세분화됩니다.

적응증은 암, 감염, 자가염증성 질환, 자가면역질환, 중추신경계질환 등 5가지로 분류됩니다. 암 분야는 시장을 독점하고 있습니다. 암에 효과적인 치료법의 급속한 개발이 이 분야의 성장을 뒷받침하고 있습니다.

시장은 투여 경로별로 정맥내, 피하, 기타 3가지로 분류됩니다. 정맥내 투여가 시장을 독점하고 있어 예측 기간 동안에도 그 우위성을 유지할 것으로 보입니다. 피하 투여 경로의 채용 확대가 시장 성장을 뒷받침할 것으로 보입니다.

시장은 최종 사용자별로 바이오제약기업, 연구기관 등 3가지로 분류됩니다. 바이오 제약 기업 부문이 시장을 독점하고 있으며 예측 기간 동안에도 우위를 유지할 것으로 보입니다. 신약과 개량약에 대한 요구 증가가 치료제 수요를 밀어 올리고 있습니다.

이중 특이성 항체 치료제 위탁생산 시장 - 지리적 인사이트

지역적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카의 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 전개하는 국가에 따라 더 나뉩니다.

이중 특이성 항체 치료제 위탁생산 시장 - 경쟁 구도:

이중 특이성 항체 치료제 위탁생산 시장은 그 성질상 중간 정도의 경쟁 상태에 있습니다. 이 시장의 주요 기업은 M&A, 제휴, 연구 개발 활동 등 조직 내 전략적 이니셔티브를 채택하기 위해 노력하고 있습니다. 예를 들어, 유럽 위원회는 2022년 6월 CD20xCD3 T 세포 결합제 bsAB Lunsumio(mosunetuzumab)의 조건부 판매를 승인했습니다. 재발 또는 저항성 여포성 림프종 환자에게 적용됩니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석- 이중 특이성 항체 치료제 위탁생산업

경쟁 대시보드
기업 프로파일
- Lonza Group
- Roche's
- Thermo Fisher Scientific
- Creative Biolabs
- AbbVie
- Amgen
- Janssen
- Johnson &Johnson
- IQVIA
- WuXi Biologics
- Context Therapeutics
- Sino Biological Inc.
- KBI Biopharma
- Others

제12장 애널리스트의 전방위 전망

BJH 24.02.13

REPORT HIGHLIGHT

Bispecific Antibody Therapeutics Contract Manufacturing Market size was valued at USD 5,289.1 Million in 2022, expanding at a CAGR of 36.23% from 2023 to 2030.

Therapeutics using bispecific antibodies Contract manufacturing is the practice of contracting out to specialist contract manufacturing organizations (CMOs) the manufacturing procedures involved in creating bispecific antibodies. Bispecific antibodies are a class of medicinal compounds designed to target two different antigens at the same time. These antigens are frequently found on the surface of cells that are linked to diseases such as infectious diseases, autoimmune disorders, and cancer.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Market Dynamics

Increasing emphasis on novel therapeutics development and R&D investment to propel market demand

During the forecast period, the market for contract manufacturing of bispecific antibody (bsAB) therapies is expected to grow primarily due to increased research and development efforts aimed at finding new therapeutics. The market has been seeing exponential expansion over the last few years, and this trend is expected to continue over the analysis period. The main reason for this is the strong pipeline of bispecific antibodies that will probably be introduced throughout the projection period. Moreover, a key driver of the market's profitable expansion is the expanding pipeline of anti-cancer treatments. For example, according to the U.S. FDA, more than 85% of bispecific antibodies in clinical trials are intended to treat cancer as of 2022.

Furthermore, as bispecific antibody therapies have such significant therapeutic potential in treating cancer and other disorders, there has been an increase in demand for them since the pandemic. Moreover, several bispecific antibodies are now in the early stages of clinical development. Therefore, in the upcoming years, it is anticipated that this aspect will positively affect market growth. Furthermore, there is a developing pipeline of bispecific antibody therapies, which is anticipated to boost market expansion opportunities.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 36.23% over the forecast period (2023-2030)

Based on Indication segmentation, cancer segment was predicted to show maximum market share in the year 2022, owing to high need for cancer immunotherapy.

Based on Route of Administration segmentation, intravenous segment was the leading segment in 2022, mainly due to its effectiveness in cancer and immune system building.

Based on End-User segmentation, biopharmaceutical companies' segment was the leading segment in 2022, mainly due to increasing demand from clinical trials.

On the basis of region, North America was the leading revenue generator in 2022, owing to high R&D and novel drugs discovery.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Segmentation Analysis:

The Global Bispecific Antibody Therapeutics Contract Manufacturing Market is segmented on the basis of Indication, Route of Administration, End-User, and Region.

The market is divided into five categories based on Indication: cancer, infectious diseases, autoinflammatory and autoimmune diseases, CNS Conditions, and others. The cancer segment dominates the market. Rapid developments in cancer effective therapies are boosting segment growth.

The market is divided into three categories based on Route of Administration: intravenous, subcutaneous, and others. The intravenous segment dominates the market and is likely to maintain its dominance during the forecast period. The growing adoption of the subcutaneous route of administration is likely to boost market growth.

The market is divided into three categories based on End-User: biopharmaceutical companies, research institutes, and others. The biopharmaceutical companies segment dominates the market and is likely to maintain its dominance during the forecast period. Increased need for new and improved drugs is boosting the therapeutics demand.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Competitive Landscape:

Bispecific antibody therapeutics contract manufacturing market is moderately competitive in nature. The major players in the market are engaged on the adoption of in-organic strategic initiatives, such as mergers & acquisitions, partnerships, and R&D activities. For example, the European Commission authorized the conditional marketing of bsAB Lunsumio (mosunetuzumab), a CD20xCD3 T-cell binding drug, in June 2022. It will be applied to patients with relapsed or resistant follicular lymphoma.

Recent Developments:

In March 2023, InvoX Pharma Limited reported that F-star, a subsidiary of InvoX, has agreed to collaborate with Takeda on an immuno-oncology bsAB.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET KEY PLAYERS

Lonza Group
Roche's
Thermo Fisher Scientific
Creative Biolabs
AbbVie
Amgen
Janssen
Johnson & Johnson
IQVIA
WuXi Biologics
Context Therapeutics
Sino Biological Inc.
KBI Biopharma
Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY INDICATION

Cancer
Infectious diseases
Autoinflammatory and autoimmune diseases
CNS Conditions
Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY ROUTE OF ADMINISTRATION

Intravenous
Subcutaneous
Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY END-USER

Biopharmaceutical companies
Research institutes
Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Bispecific Antibody Therapeutics Contract Manufacturing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Indication
- 2.1.2. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Route of Administration
- 2.1.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by End-User
- 2.1.4. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Country
- 2.1.5. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Region
2.2. Competitive Insights

3. Bispecific Antibody Therapeutics Contract Manufacturing Key Market Trends

3.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Bispecific Antibody Therapeutics Contract Manufacturing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Opportunities
3.4. Bispecific Antibody Therapeutics Contract Manufacturing Market Future Trends

4. Bispecific Antibody Therapeutics Contract Manufacturing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Bispecific Antibody Therapeutics Contract Manufacturing Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Bispecific Antibody Therapeutics Contract Manufacturing Market Landscape

6.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Bispecific Antibody Therapeutics Contract Manufacturing Market - By Indication

7.1. Overview
- 7.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
- 7.1.2. Cancer
- 7.1.3. Infectious diseases
- 7.1.4. Autoinflammatory and autoimmune diseases
- 7.1.5. CNS Conditions
- 7.1.6. Others

8. Bispecific Antibody Therapeutics Contract Manufacturing Market - By Route of Administration

8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
- 8.1.2. Intravenous
- 8.1.3. Subcutaneous
- 8.1.4. Others

9. Bispecific Antibody Therapeutics Contract Manufacturing Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
- 9.1.2. Biopharmaceutical companies
- 9.1.3. Research institutes
- 9.1.4. Others

10. Bispecific Antibody Therapeutics Contract Manufacturing Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bispecific Antibody Therapeutics Contract Manufacturing Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Lonza Group
- 11.2.2. Roche's
- 11.2.3. Thermo Fisher Scientific
- 11.2.4. Creative Biolabs
- 11.2.5. AbbVie
- 11.2.6. Amgen
- 11.2.7. Janssen
- 11.2.8. Johnson & Johnson
- 11.2.9. IQVIA
- 11.2.10. WuXi Biologics
- 11.2.11. Context Therapeutics
- 11.2.12. Sino Biological Inc.
- 11.2.13. KBI Biopharma
- 11.2.14. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 3,250

￦ 4,702,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,650

￦ 6,728,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650

￦ 8,174,000

※ 부가세 별도